Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors

BACKGROUND: HIV-1 Protease Inhibitors, namely PIs, originally designed to inhibit HIV-1 aspartic protease, can modulate the immune response by mechanisms largely unknown, and independent from their activity on viral replication. Here, we analyzed the ability of PIs to interfere with differentiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Giardino Torchia, Maria Letizia, Ciaglia, Elena, Masci, Anna Maria, Vitiello, Laura, Fogli, Manuela, la Sala, Andrea, Mavilio, Domenico, Racioppi, Luigi
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883582/
https://www.ncbi.nlm.nih.gov/pubmed/20548796
http://dx.doi.org/10.1371/journal.pone.0011052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883582/
https://www.ncbi.nlm.nih.gov/pubmed/20548796
http://dx.doi.org/10.1371/journal.pone.0011052

Ejemplares similares